Nanjing CoreTech biomedical Co.,Ltd. welcome visit website http://www.china-core-tech.com. which is controlled by the Nanjing New Industrial Investment Group was founded in 2002.The company which takes the aim at industrialization is a biomedical research institute. It has two core businesses which are API and intermediate research and industrialization, biomedical R and D outsourcing. In the aspect of API and pharmaceutical intermediates, such as CAS 475086-01-2,656247-18-6,856867-55-5,69559-11-1,913611-97-9,41294-56-8,54573-75-0,93129-94-3,111594-58-2.the company has successfully developed more than 120 new drugs,of which 70 can be long-term stably supplied to domestic and foreign customers. The quality of Products achieve to international standards such as European pharmacopoeia standard, American pharmacopoeia standard. In the aspect of biomedical R and D outsourcing, the company has developed 4 innovative medicines and got 26 drug registration approvals of CFDA. The company with 41 patents at home and abroad won 50 science projects from government. It is the "International cooperation Demonstration base", " Biomedical science and Technology public service platform of Jiangsu Province"," Enterprise Academician workstation of Jiangsu Province " etc. The R & D and incubati… Click for details>>